Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 749 Good news/Bad news

749 Good news/Bad news

posted on Nov 23, 2009 02:39PM

Bad News is that we apparently are going to have to re-argue stuff that has already been argued. At least that is the way it looks to me.

As an example, in the present office action claim 1 is anticipated by Transputer T1414 data sheet, May 948, MacGregor MC68020, and Koopman.

This is a quote from the office action of 4/8/09 in reexam 90/009389 page 8 of 17.

"Thus with respect to claim 1, the above noted references of May, McGregor and Koopman are not seen to raise a substantial new question of patentability as to claim 1 of the 749 patent."

The T1414 was argued as a result of a 7/24/09 office action in 90/010520.

Good news is that at least we are familiar with the references, and have already successfully argued them. Cut and paste from prior arguments? I do hope we see some kind of official protest lodged against this examiner.

GLTA, Opty

Share
New Message
Please login to post a reply